Envestnet Asset Management »

Crinetics Pharmaceuticals In shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0M 42k 46.81

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Envestnet Asset Management

Top funds holding Crinetics Pharmaceuticals In

BlackRock
Point72 Asset Management
FMR
EcoR1 Capital
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Paradigm Biocapital Advisors
Jennison Associates
T. Rowe Price Investment Management
Henderson Group
First Light Asset Management
Perceptive Advisors
Geode Capital Management
Artal Group

View all funds holding Crinetics Pharmaceuticals In